294 related articles for article (PubMed ID: 20739291)
1. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.
Donkin JJ; Stukas S; Hirsch-Reinshagen V; Namjoshi D; Wilkinson A; May S; Chan J; Fan J; Collins J; Wellington CL
J Biol Chem; 2010 Oct; 285(44):34144-54. PubMed ID: 20739291
[TBL] [Abstract][Full Text] [Related]
2. The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E.
Namjoshi DR; Martin G; Donkin J; Wilkinson A; Stukas S; Fan J; Carr M; Tabarestani S; Wuerth K; Hancock RE; Wellington CL
PLoS One; 2013; 8(1):e53529. PubMed ID: 23349715
[TBL] [Abstract][Full Text] [Related]
3. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1.
Stukas S; May S; Wilkinson A; Chan J; Donkin J; Wellington CL
Biochim Biophys Acta; 2012 Mar; 1821(3):536-46. PubMed ID: 21889608
[TBL] [Abstract][Full Text] [Related]
4. Role of Liver X Receptor in AD Pathophysiology.
Sandoval-Hernández AG; Buitrago L; Moreno H; Cardona-Gómez GP; Arboleda G
PLoS One; 2015; 10(12):e0145467. PubMed ID: 26720273
[TBL] [Abstract][Full Text] [Related]
5. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
6. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
Corona AW; Kodoma N; Casali BT; Landreth GE
J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
[TBL] [Abstract][Full Text] [Related]
7. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
[TBL] [Abstract][Full Text] [Related]
8. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
[TBL] [Abstract][Full Text] [Related]
9. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.
Hirsch-Reinshagen V; Maia LF; Burgess BL; Blain JF; Naus KE; McIsaac SA; Parkinson PF; Chan JY; Tansley GH; Hayden MR; Poirier J; Van Nostrand W; Wellington CL
J Biol Chem; 2005 Dec; 280(52):43243-56. PubMed ID: 16207707
[TBL] [Abstract][Full Text] [Related]
10. ABCA1/ApoE/HDL Pathway Mediates GW3965-Induced Neurorestoration After Stroke.
Cui X; Chopp M; Zhang Z; Li R; Zacharek A; Landschoot-Ward J; Venkat P; Chen J
Stroke; 2017 Feb; 48(2):459-467. PubMed ID: 28028143
[TBL] [Abstract][Full Text] [Related]
11. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R
PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068
[TBL] [Abstract][Full Text] [Related]
13. ApoE promotes the proteolytic degradation of Abeta.
Jiang Q; Lee CY; Mandrekar S; Wilkinson B; Cramer P; Zelcer N; Mann K; Lamb B; Willson TM; Collins JL; Richardson JC; Smith JD; Comery TA; Riddell D; Holtzman DM; Tontonoz P; Landreth GE
Neuron; 2008 Jun; 58(5):681-93. PubMed ID: 18549781
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation.
Hu Y; Yang Y; Yu Y; Wen G; Shang N; Zhuang W; Lu D; Zhou B; Liang B; Yue X; Li F; Du J; Bu X
J Med Chem; 2013 Aug; 56(15):6033-53. PubMed ID: 23844653
[TBL] [Abstract][Full Text] [Related]
15. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
16. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease.
Riddell DR; Zhou H; Comery TA; Kouranova E; Lo CF; Warwick HK; Ring RH; Kirksey Y; Aschmies S; Xu J; Kubek K; Hirst WD; Gonzales C; Chen Y; Murphy E; Leonard S; Vasylyev D; Oganesian A; Martone RL; Pangalos MN; Reinhart PH; Jacobsen JS
Mol Cell Neurosci; 2007 Apr; 34(4):621-8. PubMed ID: 17336088
[TBL] [Abstract][Full Text] [Related]
17. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
[TBL] [Abstract][Full Text] [Related]
18. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.
Fitz NF; Cronican A; Pham T; Fogg A; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2010 May; 30(20):6862-72. PubMed ID: 20484628
[TBL] [Abstract][Full Text] [Related]
20. Liver X Receptor Agonist GW3965 Regulates Synaptic Function upon Amyloid Beta Exposure in Hippocampal Neurons.
Báez-Becerra C; Filipello F; Sandoval-Hernández A; Arboleda H; Arboleda G
Neurotox Res; 2018 Apr; 33(3):569-579. PubMed ID: 29297151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
